Hvsen Biotechnology Co., Ltd. (300871.SZ) SHZ
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 4.19B |
| Enterprise Value | 4.08B |
| P/E Ratio | 15.7 |
| PEG Ratio | 0.03 |
| Price/Sales Ratio | 2.64 |
| Price/Book Ratio | 2.03 |
| Enterprise/Revenue | 2.76 |
| Enterprise/EBITDA | 11.34 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.16 |
| Operating Margin | 0.19 |
AD
Management Effectiveness
| Return On Assets | 0.09 |
| Return On Equity | 0.13 |
Income Statement
| Revenue | 1.68B |
| Revenue/Share | 8.66 |
| Gross Profit | 520.99M |
| EBITDA | 422.63M |
| Net Income | 253.16M |
| Diluted EPS | 1.25 |
Balance Sheet
| Total Cash | 610.25M |
| Total Cash/Share | 3.04 |
| Total Debt | 617.64M |
| Total Debt/Equity | 0.27 |
| Current Ratio | 1.93 |
| Book Value Per Share | 11.28 |
Price History
| 52-Week Change | 10.81 |
| 52-Week High | 32.62 |
| 52-Week Low | 19.08 |
| Moving Average 50 Days | 24.24 |
| Moving Average 200 Days | 23.49 |
Statistics
| Average Volume | 8.44M |
| Shares Outstanding | 201.78M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.21 |
| Trailing Annual Dividend Yield | 0.91 |
| Payout Ratio | 0.09 |
| Last Split Factor | 3:2 |
| Last Split Date | May 10, 2021 |
AD
